TIM-3 as a new therapeutic target in systemic lupus erythematosus

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 395-398

  Pan, Hai Feng ^a   Zhang, Ning ^a   Li, Wen Xian ^a   Tao, Jin Hui ^b   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Systemic lupus erythematosus; Therapeutic target; TIM 3

Indexed keywords

AUTOANTIBODY; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 2; KIDNEY INJURY MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS;

MUS;

EID: 77949264241     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9833-7     Document Type: Review

References (25)

1. K Koguchi DE Anderson L Yang, et al. 2006 Dysregulated T cell expression of TIM3 in multiple sclerosis J Exp Med 203 1413 1418 10.1084/jem.20060210 1:CAS:528:DC%2BD28XmtVansb0%3D 16754722 (Pubitemid 43877603)
2. M Seki S Oomizu KM Sakata, et al. 2008 Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Clin Immunol 127 78 88 10.1016/j.clim.2008.01. 006 1:CAS:528:DC%2BD1cXjtlGluro%3D 18282810
3. WT Du HF Zhao JH Xu, et al. 2009 The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura Hum Immunol 70 398 402 10.1016/j.humimm.2009.03.013 1:CAS:528: DC%2BD1MXmsFyitbc%3D 19332093
4. SC Chae YR Park SC Shim, et al. 2004 The polymorphisms of Th1 cell surface gene TIM-3 are associated in a Korean population with rheumatoid arthritis Immunol Lett 95 91 95 10.1016/j.imlet.2004.06.008 1:CAS:528: DC%2BD2cXmvFWksLg%3D 15325803 (Pubitemid 39119905)
5. H Niwa T Satoh Y Matsushima, et al. 2009 Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation Clin Immunol 132 184 194 10.1016/j.clim.2009.04.012 1:CAS:528:DC%2BD1MXotl2gu7Y%3D 19464955
6. Y Wang J Meng X Wang, et al. 2008 Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients Scand J Immunol 67 63 70 10.1111/j.1365-3083.2008.02071.x 1:CAS:528:DC%2BD1cXitVKis7k%3D 18052965
7. E David 2007 TIM-3 as a therapeutic target in human inflammatory diseases Expert Opin Ther Targets 11 1005 1009 10.1517/14728222.11.8.1005 (Pubitemid 47232618)
8. L Monney CA Sabatos JL Gaglia, et al. 2002 Th1-specific cell surface protein TIM-3 regulates macrophage activation and severity of an autoimmune disease Nature 415 536 541 10.1038/415536a 1:CAS:528:DC%2BD38Xht1GhtLs%3D 11823861 (Pubitemid 34130609)
9. EW Su JY Lin LP Kane 2008 TIM-1 and TIM-3 proteins in immune regulation Cytokine 44 9 13 10.1016/j.cyto.2008.06.013 1:CAS:528:DC%2BD1cXhtFOmt7rL 18706830
10. CA Sabatos S Chakravarti E Cha, et al. 2003 Interaction of TIM-3 and TIM-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance Nat Immunol 4 1102 1110 10.1038/ni988 1:CAS:528:DC%2BD3sXosVyktb0%3D 14556006 (Pubitemid 37428038)
11. E Cao X Zang UA Ramagopal, et al. 2007 T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface Immunity 26 311 321 10.1016/j.immuni.2007.01.016 1:CAS:528:DC%2BD2sXjvVSns7s%3D 17363302 (Pubitemid 46413908)
12. J Wada YS Kanwar 1997 Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin J Biol Chem 272 6078 6086 10.1074/jbc.272.9.6078 1:CAS:528:DyaK2sXhslegurg%3D 9038233 (Pubitemid 27102450)
13. R Rodriguez-Manzanet R DeKruyff VK Kuchroo, et al. 2009 The costimulatory role of TIM molecules Immunol Rev 229 259 270 10.1111/j.1600-065X.2009.00772.x 1:CAS:528:DC%2BD1MXhsFGls7nK 19426227
14. C Zhu AC Anderson A Schubart, et al. 2005 The TIM-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat Immunol 6 1245 1252 10.1038/ni1271 1:CAS:528:DC%2BD2MXhtlShurrO 16286920 (Pubitemid 43045636)
15. EL Naka VC Ponciano MA Cenedeze, et al. 2009 Detection of the TIM-3 ligand, galectin-9, inside the allograft during a rejection episode Int Immunopharmacol 9 658 662 10.1016/j.intimp.2008.11.013 1:CAS:528: DC%2BD1MXlsVeqtLs%3D 19100864
16. AC Anderson DE Anderson L Bregoli, et al. 2007 Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells Science 318 1141 1143 10.1126/science.1148536 1:CAS:528:DC%2BD2sXht1ykur3E 18006747 (Pubitemid 350134897)
17. A Sánchez-Fueyo J Tian D Picarella, et al. 2003 TIM-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance Nat Immunol 4 1093 1101 10.1038/ni987 14556005 (Pubitemid 37428037)
18. HF Pan XP Li DQ Ye 2008 Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus Nat Clin Pract Rheumatol 4 352 353 1:CAS:528:DC%2BD1cXnvVKgtbc%3D 18477998
19. CO Jacob PH van der Meide HO McDevitt 1987 In vivo treatment of (NZB×NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon J Exp Med 166 798 803 10.1084/jem.166.3.798 1:CAS:528: DyaL2sXlsleqsrY%3D 3114409 (Pubitemid 18013554)
20. L Ozmen D Roman M Fountoulakis, et al. 1995 Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferongamma receptor inhibits the onset of glomerulonephritis Eur J Immunol 25 6 12 10.1002/eji.1830250103 1:CAS:528:DyaK2MXjtlSjt7w%3D 7843255
21. D Balomenos R Rumold AN Theofilopoulos 1998 Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice J Clin Invest 101 364 371 10.1172/JCI750 1:CAS:528:DyaK1cXmtF2itg%3D%3D 9435308
22. Y Ju N Hou XN Zhang, et al. 2009 Blockade of TIM-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection Cell Mol Immunol 6 35 43 1:CAS:528: DC%2BD1MXktFGksrk%3D 19254478
23. F Wang L Wan C Zhang, et al. 2009 TIM-3-Galectin-9 pathway involves the suppression induced by CD4 +CD25+ regulatory T cells Immunobiology 214 342 349 10.1016/j.imbio.2008.10.007 1:CAS:528:DC%2BD1MXlsFSnur0%3D 19362679
24. M Nakayama H Akiba K Takeda, et al. 2009 Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation Blood 113 3821 3830 10.1182/blood-2008- 10-185884 1:CAS:528:DC%2BD1MXlt1yjsbs%3D 19224762
25. L Yang DE Anderson J Kuchroo, et al. 2008 Lack of TIM-3 immunoregulation in multiple sclerosis J Immunol 180 4409 4414 1:CAS:528:DC%2BD1cXjsVKqsrs%3D 18354161